Scancell Share Discussion Threads

[wanderer1210_0] 08/10/2017 02:59

I agree with what you say P7, but if RG had sunk my investment over a period of 3-4 years with false promises, I'd make my feelings known at the AGM. To which I must ask are you going to do this, as banging on about RG on a BB with half a dozen contributors does not get the across the point you make

[panama7] 07/10/2017 21:47

What proof other than Goodfellow's words do you have of a 2015 deal. The trials are most definitely a combined 4 years late. When the combi trial was announced we were told it would commence in 2016 and likewise Moditope was due to start in 2016. He told us in 2015 funding was easy for a company with a successful phase 2 trial behind it. What an absolute load of nonsense. The bloke has misled Investors for 5 years. He should be sacked for gross incompetence.

[chelsea35] 07/10/2017 20:36

panama7, was the 2015 deal that was never sealed "spin"?? The trials are not four years late.

Beyond that as you know from my posts the last year, yes the jury is out. What/Who would you replace RG with? Criticism is easy, constructive criticism a lot harder. Anyway, goodnight.

[panama7] 07/10/2017 20:15

Chelsea, of course it's all spin, you had an email from Goodfellow stating everything is on track and going to plan when nothing could be further from the truth. Nothing is on track, trials are a total of 4 years late from their first original dates, there is no funding in place to pay for the trials, no deals and no sale. The bloke's incompetence is breathtaking, he tells you what you want to hear and you lap it up. you have held your shares for 5 years and if you needed your money tomorrow you would incur a massive loss and that is down to Goodfellow's failings

[chelsea35] 07/10/2017 11:21

panama7, I don"t actually refer to it as "spin". It is the opinion that is important, particularly now as some time has passed since you first stated it and was perhaps a bit premature.

Just hoping we are in a better position now after a year of further clinical development to command deals or a raising at a mutually beneficial value. Not holding my breath, the lack or existence of buying pre AGM is noteworthy.

[panama7] 07/10/2017 10:27

Chelsea, Balerno only sounds like me because he is also questioning Goodfellow's performance which has simply not been good enough. Even you yourself after putting up with his spin, rhetoric and non delivery for 4 years are starting to think differently. Unless he pulls a rabbit out of the hat in the next 72 hours his time is up.

[chelsea35] 06/10/2017 21:18

goosed, and we all complained at raising at 17p lol !! ATB

[gooosed] 06/10/2017 17:14

AGM 2016 - "Mindful" as Chiplin said he was of the previous to last cash raise being at 17p & then going out and scooping up approx. 1m Shs @ 10p when PI's were denied the same opportunity . . . . . I wonder if anyone attending this years jamboree will ask what value there is in having significant costs (US Office & BoD members) gnawing away at funds raised, yeup, right back here in old Blighty ?

[supernumerary] 05/10/2017 19:00

'Conclusions
This systematic evaluation of oncology approvals by the
EMA in 2009-13 shows that most drugs entered the market without
evidence of benefit on survival or quality of life. At a minimum of 3.3
years after market entry, there was still no conclusive evidence that
these drugs either extended or improved life for most cancer indications.
When there were survival gains over existing treatment options or
placebo, they were often marginal.'

[agema] 05/10/2017 07:20

A.G.M.

Like always the BOD’s will fill you all with a jam tomorrow story.

All that matters now, is when and if full funding has been secured, and at what dilution.

[gooosed] 04/10/2017 17:20

Cheers chelsea35

[chelsea35] 04/10/2017 16:50

Goosed, botski is attending the AGM and taping it. Will be posted on LSE,I can always post it here.

[gooosed] 04/10/2017 16:20

Anyone here attending the AGM ?

[chelsea35] 04/10/2017 15:57

Well it has covered the expenditure of at least the period we have lost during the SCIB1 manufacture. Just really hoping the BOD have some positive news for us. We have seen some big falls in AVO, IMM, MTFB and the manner they have pushed on after falling to new lows.

[panama7] 04/10/2017 15:38

Well all these recent fundraisings certainly put Goodfellow's " Our most successful fundraising " into perspective.

[chelsea35] 03/10/2017 08:36

Hope they are not travelling by Monarch Loz. ATB

[the real lozan] 03/10/2017 07:57

Well well - The TEA LEAF seems to have presented folks with a 'bit of a CON undrum'
My reasoning is based on info {also quoted by posters on M F F F} provided by the Sooo often referred-to Hardman Report... which der TEA LEAF appears to CLAIM = is FALSE info.
As both sources of info / reasoning.... appear to be 'at odds' with each-other, ergo =
Both sources CAN not be CORRECT
The CON undrum that folks now face is = ???
Do *WE* place our faith in the info provided by the much relied-upon / oft-quoted ... {when it suits}.. Hardman Report
OR
Do *WE* place our faith in the oft PROVEN misleading, FALSE CLAIMS of der leader of trHYPE...
.
NO CON test
.
Must prepare for guests, who are en-route to S W France
{Which der TEA LEAF also tried to tell everyone was 'not-the-case' }

[the real lozan] 02/10/2017 21:13

Hardman report , page 41 states =
The Monthly
2nd October 2017
41
Scancell
►
Results:
In 2017, the cash burn was £4.6m, 64% being spent on R&D, leaving the
company with just under £2.7m cash subsequently boosted
by the £5m Placing.
.
Make of it what one will
but
Who gives a monkey's.... what YOU say anymore ???

[inanaco] 02/10/2017 19:49

Oh Dear Loz

your maths are dreadful . nearly as bad as your actual reading of the accounts as you have not taken into account the tax rebate. The expenditure is ever changing at present, so you cannot predict a precise cash burn.

""Together with our existing cash resources and anticipated R&D tax credits "" from the RNS.

You Posted ..... "In 2017, the cash burn was 4.6m"

actual was £3.55m after tax

with the actual cash position of at (£3.8m) which is down to not receiving all the tax credit from 2016/17 by April 2017,

so you should work on the £3.55m as the base cash burn as that tax credit will now have been received.

so your numbers are already £1m plus out ... but then your astute .. Lord Haw Haw ..

[inanaco] 30/9/2017 14:59

well worth watching



how the EU could reform .... but can't ..

Agema, all in RNS .. so what ever your concerns are, (ichor) they are priced in.